Abstract
Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons and the presence of intracytoplasmic inclusions (Lewy bodies). Iron, which is elevated in the substantia nigra (SN) of PD patients, seems to be of pivotal importance, because of its capacity to enhance the amplification of reactive-oxygen species. Therefore, it is tempting that the iron-releasing key enzyme in heme catabolism, heme oxygenase-1 (HO-1), may represent a candidate for a genetic susceptibility to PD. In the current study, we examined a (GT)n fragment length polymorphism in the promoter region, as well as three coding SNPs in the HO-1 gene in order to assess if certain genotypes are associated with PD. Furthermore, peripheral blood expression levels of HO-1 in PD patients and healthy probands were compared. However, our analyses did not reveal a significant association of these genetic markers in the HO-1 gene with an increased susceptibility to PD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- HO-1 :
-
Heme oxygenase-1
- PD:
-
Parkinson’s disease
- qRT-PCR:
-
Quantitative real-time PCR
- ROS:
-
Reactive-oxygen species
- SN:
-
Substantia nigra
- SNP:
-
Single-nucleotide polymorphism
- TCS:
-
Transcranial sonography
References
Baranano DE, Snyder SH (2001) Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci USA 98:10996–11002
Berg D (2006) Transcranial sonography in the early and differential diagnosis of Parkinson’s disease. J Neural Transm Suppl 24:9–254
Berg D, Becker G, Zeiler B et al (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53:1026–1031
Berg D, Gerlach M, Youdim MB et al (2001a) Brain iron pathways and their relevance to Parkinson’s disease. J Neurochem 79:225–236
Berg D, Jabs B, Merschdorf U et al (2001b) Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50:463–467
Berg D, Roggendorf W, Schroder U et al (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999–1005
Berg D, Hochstrasser H, Schweitzer KJ et al (2006) Disturbance of iron metabolism in Parkinson’s disease—ultrasonography as a biomarker. Neurotox Res 9:1–13
Cary NC (ed) (2003) SAS User’s Guide: Statistics. SAS Institute Inc
Chen YH, Lin SJ, Lin MW et al (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111:1–8
Dennery PA (2000) Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 36:181–199
Dore S, Takahashi M, Ferris CD et al (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 96:2445–2450
Frankel D, Mehindate K, Schipper HM (2000) Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. J Cell Physiol 185:80–86
Fung HC, Scholz S et al (2006) Genome-wide genotyping in Parkinson`s disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 5:911–916
Hellemans J, Mortier G, De Paepe A et al (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19
Kikuchi A, Yamaya M, Suzuki S et al (2005) Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 116:354–360
Kimpara T, Takeda A, Watanabe K et al (1997) Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100:145–147
Kutty RK, Kutty G, Rodriguez IR et al (1994) Chromosomal localization of the human heme oxygenase genes: heme oxygenase-1 (HMOX1) maps to chromosome 22q12 and heme oxygenase-2 (HMOX2) maps to chromosome 16p13.3. Genomics 20:513–516
Lee DW, Andersen JK, Kaur D (2006) Iron dysregulation and neurodegeneration: the molecular connection. Mol Interv 6:89–97
Llesuy SF, Tomaro ML (1994) Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochim Biophys Acta 1223:9–14
Matsuoka Y, Kitamura Y, Okazaki M et al (1998) Kainic acid induction of heme oxygenase in vivo and in vitro. Neuroscience 85:1223–1233
Mizuta I, Satake W et al (2006) Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson`s disease. Hum Mol Genet 15:1151–1158
Nakagami T, Toyomura K, Kinoshita T et al (1993) A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158:189–193
Raymond M, Rousset F (1995) GENEPOP (Version 1.2): Population Genetics Software for Exact Tests and Ecumenicism 86:248–249
Rouault TA (2001) Systemic iron metabolism: a review and implications for brain iron metabolism. Pediatr Neurol 25:130–137
Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics methods and protocols: methods in molecular biology. Humana Press, Totowa
Schipper HM (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35:821–830
Schipper HM (2004a) Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev 3:265–301
Schipper HM (2004b) Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress. Ann N Y Acad Sci 1012:84–93
Schipper HM, Liberman A, Stopa EG (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson’s disease. Exp Neurol 150:60–68
Shibahara S (1994) Heme oxygenase–regulation of and physiological implication in heme catabolism. In: Fujita H (ed) Regulation of heme protein synthesis. AlphaMed Press, Dayton
Stocker R, Yamamoto Y, McDonagh AF et al (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046
Yamada N, Yamaya M, Okinaga S et al (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66:187–195
Yasuda H, Okinaga S, Yamaya M et al (2006) Association of susceptibility to the development of pneumonia in the older Japanese population with heme oxygenase-1 gene promoter polymorphism. J Med Genet 43:e17
Zhang J, Piantadosi CA (1992) Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 90:1193–1199
Acknowledgments
We are grateful to Claudia Schulte (Hertie Institute of Clinical Brain Research, University of Tuebingen) for technical assistance and for helpful discussions. This work was supported by the National Genome Research Network (NGFNplus).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Funke, C., Tomiuk, J., Riess, O. et al. Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson’s disease patients. J Neural Transm 116, 853–859 (2009). https://doi.org/10.1007/s00702-009-0237-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-009-0237-6